Navigation
Recherche
|
Blocked From Selling Off-Brand Ozempic, Telehealth Startups Embrace a Less Effective Drug
jeudi 15 mai 2025, 12:00 , par Wired: Tech.
As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 medication injected daily instead of weekly.
https://www.wired.com/story/telehealth-pivot-liraglutide-fda-shortage/
Voir aussi |
56 sources (32 en français)
Date Actuelle
dim. 18 mai - 18:25 CEST
|